(Q50519236)

English

Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy.

scientific article published on 7 June 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

1 reference

based on heuristic

inferred from title

author name string

Kyu Seop Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

Won Ki Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

publication date

7 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

Japanese Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

55

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

370-377

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

Treatment of polypoidal choroidal vasculopathy with photodynamic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

A study comparing two protocols of treatment with intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Intravitreal bevacizumab for neovascular age-related macular degeneration with or without prior treatment with photodynamic therapy: one-year results

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0045-Z

21 January 2018

Identifiers

10.1007/S10384-011-0045-Z

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21647565

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50519236&oldid=2210335142"